← Back to Clinical Trials
Recruiting NCT04142047

NCT04142047 Skeletal Muscle Energetics and Fatiguability in Older Individuals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04142047
Status Recruiting
Phase
Sponsor Johns Hopkins University
Condition HIV
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2019-09-05
Primary Completion 2027-07-01

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age 90 Years
Study Type OBSERVATIONAL
All Conditions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2019-09-05 with a primary completion date of 2027-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators are studying whether metabolic abnormalities in calf (leg) muscle in older people with and others without HIV are associated with decreased abilities to exercise.

Eligibility Criteria

Inclusion Criteria: * Participants who are \>= 60 years of age * HIV serostatus positive participants on stable antiretroviral therapy (ART) (no regimen change in last month) with undetectable HIV viral load (\<100 copies). * HIV serostatus negative participants Exclusion Criteria: * Unable to understand the risks, benefits, and alternatives of participation and give meaningful consent * Contraindications to MRI * Significant cardiovascular, pulmonary or musculoskeletal or orthopedic disease that significantly limits exercise capacity * Significant lower extremity peripheral vascular disease. * Weight greater than 350 lbs * Cognitive or speech impairments that would limit completion of questionnaires or fatigue reporting.

Contact & Investigator

Central Contact

Maria Esteban, RN, BSN

✉ mesteba1@jh.edu

📞 410-955-1160

Principal Investigator

Robert G Weiss, MD

PRINCIPAL INVESTIGATOR

Johns Hopkins University

Frequently Asked Questions

Who can join the NCT04142047 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, up to 90 Years, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04142047 currently recruiting?

Yes, NCT04142047 is actively recruiting participants. Contact the research team at mesteba1@jh.edu for enrollment information.

Where is the NCT04142047 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT04142047 clinical trial?

NCT04142047 is sponsored by Johns Hopkins University. The principal investigator is Robert G Weiss, MD at Johns Hopkins University. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology